| 704 |
Disopyramide
|
-
Disopyramide, CAS-RN: 3737-09-5, DTXSID1045536
|
None
|
| 705 |
Procainamide
|
-
Procainamide, CAS-RN: 51-06-9, DTXSID7023512
|
None
|
| 706 |
Terfenadine
|
-
Terfenadine, CAS-RN: 50679-08-8, DTXSID2023642
|
2 AOPs
|
| 707 |
Cisapride
|
-
Cisapride, CAS-RN: 81098-60-4, DTXSID3022825
|
2 AOPs
|
| 708 |
Tetraarsenic trioxide
|
-
Tetraarsenic trioxide, CAS-RN: 83527-54-2, DTXSID80232428
|
None
|
| 709 |
Pentamidine
|
-
Pentamidine, CAS-RN: 100-33-4, DTXSID7023431
|
None
|
| 710 |
Geldanamycin
|
-
Geldanamycin, CAS-RN: 30562-34-6, DTXSID7042691
|
None
|
| 711 |
Silver
|
-
Silver, CAS-RN: 7440-22-4, DTXSID4024305
|
4 AOPs
|
| 712 |
Gold nanoparticles
|
|
None
|
| 713 |
Chromium
|
-
Chromium, CAS-RN: 7440-47-3, DTXSID3031022
|
None
|
| 714 |
Other heavy metal effects
|
|
None
|
| 715 |
Other heavy metals
|
|
None
|
| 716 |
Cisplatin
|
-
Cisplatin, CAS-RN: 15663-27-1, DTXSID4024983
|
472: DNA adduct formation leading to kidney failure
|
| 717 |
Nanoparticles and Micrometer Particles
|
|
None
|
| 718 |
Platinum
|
|
None
|
| 719 |
2) Aluminum
|
|
None
|
| 720 |
Aluminum
|
-
Aluminum, CAS-RN: 7429-90-5, DTXSID3040273
|
None
|
| 721 |
Manganese
|
-
Manganese, CAS-RN: 7439-96-5, DTXSID2024169
|
2 AOPs
|
| 722 |
Nickel
|
-
Nickel, CAS-RN: 7440-02-0, DTXSID2020925
|
None
|
| 723 |
Zinc
|
-
Zinc, CAS-RN: 7440-66-6, DTXSID7035012
|
615: Suppression of Keap1 cysteine oxidation leading to liver inflammation
|
| 724 |
Gold
|
-
Gold, CAS-RN: 7440-57-5, DTXSID3064697
|
None
|
| 725 |
All-trans retinoic acid
|
|
615: Suppression of Keap1 cysteine oxidation leading to liver inflammation
|
| 726 |
BMS-89453
|
|
436: Inhibition of RALDH2 causes reduced all-trans retinoic acid levels, leading to transposition of the great arteries
|
| 727 |
WIN18446
|
|
None
|
| 728 |
4-diethylaminobenzaldehyde (DEAB)
|
|
436: Inhibition of RALDH2 causes reduced all-trans retinoic acid levels, leading to transposition of the great arteries
|